论文部分内容阅读
糖尿病治疗之路回顾延缓并发症发生发展是糖尿病管理的重要主题近20年糖尿病管理处于不断摸索与转变过程中,更多先进的理念不断被认可,使得患者取得更好的血糖控制,减少并发症风险,改善疾病预后建立个体花的降糖目标积极的早期强化治疗糖尿病患者得的综合管理
风雨兼程,铸就经典糖尿病管理与瑞格列奈上市20年记
【摘 要】
：
糖尿病治疗之路回顾延缓并发症发生发展是糖尿病管理的重要主题近20年糖尿病管理处于不断摸索与转变过程中,更多先进的理念不断被认可,使得患者取得更好的血糖控制,减少并发
【机 构】
：
北京大学第一医院
【出 处】
：
2017北大糖尿病论坛
【发表日期】
：
2017年5期
其他文献
卒中是人类的第二位死因,在中国为首位死因.我国现存卒中患者超过700万,居血管性疾病之首[1-4].每年新发病例100万～200万,校正年龄后卒中年发病率为(116～219) /10万,年死亡率为
会议
The Predictive value of MGMT Promoter Methylation Status in Asian and Caucasian Patients with Malign
Objective: The prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter status for survival of patients with malignant gliomas rema
目的：鼻腔副鼻窦恶性黑色素瘤发病率低，预后差。鼻腔副鼻窦恶性黑色素瘤以手术治疗为主，放疗的报道较少，其作用仍有争议。本文回顾性分析原发鼻腔副鼻窦恶性黑色素瘤52例，探讨
Spreading Patterns of Lymph Nodes and the Role of Elective Neck Irradiation for Esthesioneuroblastom
Objective: Esthesioneuroblastoma (ENB) is a rare malignant neoplasm with great controversies on management of the neck.The aim of this study is to character
目的：探讨术后131I治疗前刺激性甲状腺球蛋白(ps-Tg)＜ 10ng/ml的非远处转移性分化型甲状腺癌(DTC)患者经131I治疗后的临床转归，以及ps-Tg对DTC患者临床转归的预测价值.方法：2
Comprehensive genomic profiling of advanced cancers identifies MET exon 14 alterations that are sens
Objective: Amplifications and activating mutations in the c-MET proto-oncogene are known oncogenic drivers that have proven responsive to targeted therapy.
First-line monotherapy with nivolumab (nivo;anti-programmed death-1 [PD-1]) in advanced NSCLCsafety,
Objective: Nivo, a fully human IgG4 PD-1 immune checkpoint inhibitor antibody, has demonstrated durable responses and tolerability in heavily pretreated pat
Objective: Nivo, a fully human IgG4 programmed death-1 immune checkpoint inhibitor antibody, has demonstrated durable responses and tolerability in heavily
The prevalence of obesity and diabetes in China is increasing at an alarming rate.It is appropriate to call this a diabetes emergency.This emergency has led to
会议
Disclosures I will discuss use of METRELEPTIN for lipodystraphy (not approved for PLD and NASH) I am receiving drug and research support from Aegerion.Worked as
会议